Skip to main content
Grant Details

Grant Number: 5UM1CA221939-05 Interpret this number
Primary Investigator: Ritzwoller, Debra
Organization: Kaiser Foundation Research Institute
Project Title: Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations
Fiscal Year: 2022


Abstract

PROJECT SUMMARY / ABSTRACT Lung cancer, the most significant cause of cancer deaths in the US, is an urgent public health threat. It disproportionately affects populations that are already plagued by high poverty rates and low education levels. These populations experience both health disparities in the early diagnosis and treatment of cancer and are historically difficult to reach with cancer screening initiatives. While the results from the National Lung Screening Trial (NLST) indicated that low dose CT (LDCT) is an efficacious and cost-effective strategy for lung cancer screening (LCS), many uncertainties exist with respect to how patient, provider, health system, and societal factors may impact the quality, compliance, effectiveness, and the risk of harms associated with lung cancer screening, within community-based health systems who serve diverse populations. Spanning from Pennsylvania to Hawaii and including five heterogeneous health systems with diverse populations, our proposed PROSPR Research Center, the Center for Research to Optimize Precision Lung Cancer Screening (CPLS), brings together a team of experienced, interdisciplinary researchers and clinicians with long-standing collaborative ties that is well-positioned to pursue research related to the barriers and opportunities associated with the implementation of LCS programs within community settings. The health systems within CPLS include: Henry Ford Health System in Metro Detroit, Kaiser Permanente Colorado, Kaiser Permanente Hawaii, Marshfield Clinic Health System in rural Wisconsin, and University of Pennsylvania Health System. The ultimate goal of CPLS is to identify critical gaps in the LCS process and to design innovative multilevel interventions to reduce lung cancer mortality, particularly among underserved populations. To achieve this goal, CPLS will complete the following specific aims: 1) build a comprehensive data ecosystem by pooling and linking common data elements to capture the entire LCS process and to assess the patient, provider, facility, health system, and societal factors that affect LCS; 2) leverage the CPLS data resource to conduct four high- impact, observational studies of the multilevel factors associated with the LCS process; 3) based on findings from Aims 1 and 2, develop and test interventions to address identifiable gaps in care that may lead to health disparities in LCS, 4) actively participate in Trans-PROSPR research initiatives and collaborate with external investigators via the use of publicly-available CPLS datasets. Our center focuses on the inclusion of diverse, underserved populations that are defined by multiple factors that may adversely impact access to, and utilization of, cancer screening. In response to both the Surgeon General’s strong emphasis on the need to reduce lung cancer mortality and the Cancer Moonshot Blue Ribbon Panel’s focus on reducing the disproportionately high cancer death rates in underserved populations, CPLS will serve as a model for high- impact, translational research to reduce disparities in cancer mortality.



Publications

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
Authors: Beaber E.F. , Kamineni A. , Burnett-Hartman A.N. , Hixon B. , Kobrin S.C. , Li C.I. , Oliver M. , Rendle K.A. , Skinner C.S. , Todd K. , et al. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022-08-02; 31(8), p. 1521-1531.
PMID: 35916603
Related Citations

Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions.
Authors: Shih Y.T. , Sabik L.M. , Stout N.K. , Halpern M.T. , Lipscomb J. , Ramsey S. , Ritzwoller D.P. .
Source: Journal of the National Cancer Institute. Monographs, 2022-07-05; 2022(59), p. 42-50.
PMID: 35788368
Related Citations

Weaving Equity into the Fabric of Medical Research.
Authors: Chaiyachati K.H. , Beidas R.S. , Lane-Fall M.B. , Rendle K.A. , Shelton R.C. , Kaufman E.J. .
Source: Journal of general internal medicine, 2022 06; 37(8), p. 2067-2069.
EPub date: 2022-03-01.
PMID: 35233707
Related Citations

Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.
Authors: Burnett-Hartman A.N. , Carroll N.M. , Honda S.A. , Joyce C. , Mitra N. , Neslund-Dudas C. , Olaiya O. , Rendle K.A. , Schnall M.D. , Vachani A. , et al. .
Source: Annals of the American Thoracic Society, 2022 03; 19(3), p. 433-441.
PMID: 34543590
Related Citations

Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-up Care: A Multicenter Cohort Study.
Authors: Kim R.Y. , Rendle K.A. , Mitra N. , Saia C.A. , Neslund-Dudas C. , Greenlee R.T. , Burnett-Hartman A.N. , Honda S.A. , Simoff M.J. , Schapira M.M. , et al. .
Source: Annals of the American Thoracic Society, 2022-02-15; , .
EPub date: 2022-02-15.
PMID: 35167781
Related Citations

Lung Cancer Screening by Race and Ethnicity in an Integrated Health System in Hawaii.
Authors: Oshiro C.E.S. , Frankland T.B. , Mor J. , Wong C.P. , Martinez Y.T. , Aruga C.K.K. , Honda S. .
Source: JAMA network open, 2022-01-04; 5(1), p. e2144381.
EPub date: 2022-01-04.
PMID: 35050353
Related Citations

Four strategic areas to advance equitable implementation of evidence-based practices in cancer care.
Authors: Rendle K.A. , Beidas R.S. .
Source: Translational behavioral medicine, 2021-11-30; 11(11), p. 1980-1988.
PMID: 34850931
Related Citations

Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Authors: Ritzwoller D.P. , Meza R. , Carroll N.M. , Blum-Barnett E. , Burnett-Hartman A.N. , Greenlee R.T. , Honda S.A. , Neslund-Dudas C. , Rendle K.A. , Vachani A. .
Source: JAMA network open, 2021-10-01; 4(10), p. e2128176.
EPub date: 2021-10-01.
PMID: 34636916
Related Citations

Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond.
Authors: Croswell J.M. , Corley D.A. , Lafata J.E. , Haas J.S. , Inadomi J.M. , Kamineni A. , Ritzwoller D.P. , Vachani A. , Zheng Y. , National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) II Consortium .
Source: Preventive medicine, 2021 10; 151, p. 106595.
EPub date: 2021-06-30.
PMID: 34217414
Related Citations

Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium.
Authors: National Cancer Institute’s PROSPR Consortium , Corley D.A. , Sedki M. , Ritzwoller D.P. , Greenlee R.T. , Neslund-Dudas C. , Rendle K.A. , Honda S.A. , Schottinger J.E. , Udaltsova N. , et al. .
Source: Gastroenterology, 2021 03; 160(4), p. 999-1002.
EPub date: 2020-10-21.
PMID: 33096099
Related Citations

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
Authors: Mazzone P.J. , Gould M.K. , Arenberg D.A. , Chen A.C. , Choi H.K. , Detterbeck F.C. , Farjah F. , Fong K.M. , Iaccarino J.M. , Janes S.M. , et al. .
Source: Chest, 2020 07; 158(1), p. 406-415.
EPub date: 2020-04-23.
PMID: 32335067
Related Citations

Lessons Learned to Promote Lung Cancer Screening and Preempt Worsening Lung Cancer Disparities.
Authors: Burnett-Hartman A.N. , Wiener R.S. .
Source: American journal of respiratory and critical care medicine, 2020-04-15; 201(8), p. 892-893.
PMID: 31905007
Related Citations

Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
Authors: Carroll N.M. , Burnett-Hartman A.N. , Joyce C.A. , Kinnard W. , Harker E.J. , Hall V. , Steiner J.S. , Blum-Barnett E. , Ritzwoller D.P. .
Source: Journal of general internal medicine, 2020 04; 35(4), p. 1143-1152.
EPub date: 2020-01-23.
PMID: 31974902
Related Citations

Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Authors: Rendle K.A. , Burnett-Hartman A.N. , Neslund-Dudas C. , Greenlee R.T. , Honda S. , Elston Lafata J. , Marcus P.M. , Cooley M.E. , Vachani A. , Meza R. , et al. .
Source: Cancer prevention research (Philadelphia, Pa.), 2020 02; 13(2), p. 129-136.
EPub date: 2019-12-23.
PMID: 31871221
Related Citations




Back to Top